IN2013DE00726A - - Google Patents

Download PDF

Info

Publication number
IN2013DE00726A
IN2013DE00726A IN726DE2013A IN2013DE00726A IN 2013DE00726 A IN2013DE00726 A IN 2013DE00726A IN 726DE2013 A IN726DE2013 A IN 726DE2013A IN 2013DE00726 A IN2013DE00726 A IN 2013DE00726A
Authority
IN
India
Prior art keywords
chimeric gene
fusion protein
toxins
perfringens
alpha
Prior art date
Application number
Other languages
English (en)
Inventor
Siva Ramakrishna Uppalapati
Joesph Kingston Jeyabalaji
Harishchandra Sripathy Murali
Harsh Vardhan Batra
Original Assignee
Director General Defence Res And Dev Organization
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Director General Defence Res And Dev Organization filed Critical Director General Defence Res And Dev Organization
Priority to IN726DE2013 priority Critical patent/IN2013DE00726A/en
Publication of IN2013DE00726A publication Critical patent/IN2013DE00726A/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
IN726DE2013 2013-03-13 2013-03-13 IN2013DE00726A (enExample)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN726DE2013 IN2013DE00726A (enExample) 2013-03-13 2013-03-13

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN726DE2013 IN2013DE00726A (enExample) 2013-03-13 2013-03-13

Publications (1)

Publication Number Publication Date
IN2013DE00726A true IN2013DE00726A (enExample) 2015-06-26

Family

ID=54394176

Family Applications (1)

Application Number Title Priority Date Filing Date
IN726DE2013 IN2013DE00726A (enExample) 2013-03-13 2013-03-13

Country Status (1)

Country Link
IN (1) IN2013DE00726A (enExample)

Similar Documents

Publication Publication Date Title
PH12018501280A1 (en) Anti-myostatin antibodies, polypeptides containing variant fc regions, and methods of use
PH12017501115A1 (en) Anti-myostatin antibodies, polypeptides containing variant fc regions, and method of use
MX2023008559A (es) Proteínas de fusión fc heterodiméricas il15/il15ra.
PH12020550205A1 (en) IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE
MX2023007211A (es) Anticuerpos antimiostatina y metodos de uso.
ZA201703241B (en) Anti-c5 antibodies and methods of use
PE20210107A1 (es) Anticuerpos anti-cd3 y metodos de uso
SG10201909180SA (en) Humanized anti-c1s antibodies and methods of use thereof
EP4303232A3 (en) Chimeric antigen receptor and methods of use thereof
UY34227A (es) Acido nucleico recombinante que codifica el gen de la toxina axmi270, vectores, células, plantas y sus métodos de empleo
MX383142B (es) Composiciones que comprenden polipéptidos que tienen actividad xilanasa y polipéptidos que tienen actividad arabinofuranosidasa.
MX2017014397A (es) Anticuerpos anti-receptor neonatal de fragmento cristalizable(fcrn).
EP3230457A4 (en) Clostridial neurotoxin fusion proteins, propeptide fusions, their expression, and use
AU2015348922A8 (en) Codon optimized polynucleotide for high level expression of CRM197
WO2014122161A3 (en) Use of polypeptides having protease activity in animal feed
PH12016501085A1 (en) Pesticidal fusion protein improvements
NZ725212A (en) Group a streptococcus vaccine
MX2021013879A (es) Variantes de lipasa y polinucleotidos que las codifican.
MX374934B (es) Marcador de seleccion novedoso para transfeccion celular y produccion de proteinas.
MX2016006586A (es) Identificacion de una citocina de linfocitos b novedosa.
IN2013MU02316A (enExample)
MX2015009867A (es) Mutantes del factor x.
IN2013DE00726A (enExample)
MX2013013063A (es) Plantas que tienen rasgos mejorados relacionados con el rendimiento y metodo para elaborar las mismas.
BR112017010696A2 (pt) mutantes de pneumolisina e métodos de utilização deste mutante